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Abstract. 
 
CD44, the major cell surface receptor for hy-
aluronic acid (HA), was shown to localize to detergent-
resistant cholesterol-rich microdomains, called lipid 
rafts, in ﬁbroblasts and blood cells. Here, we have inves-
tigated the molecular environment of CD44 within the 
plane of the basolateral membrane of polarized mam-
mary epithelial cells. We show that CD44 partitions into 
lipid rafts that contain annexin II at their cytoplasmic 
face. Both CD44 and annexin II were released from 
these lipid rafts by sequestration of plasma membrane 
cholesterol. Partition of annexin II and CD44 to the 
same type of lipid rafts was demonstrated by cross-link-
ing experiments in living cells. First, when CD44 was 
clustered at the cell surface by anti-CD44 antibodies, 
annexin II was recruited into the cytoplasmic leaﬂet of 
CD44 clusters. Second, the formation of intracellular, 
submembranous annexin II–p11 aggregates caused by 
expression of a trans-dominant mutant of annexin II re-
sulted in coclustering of CD44. Moreover, a frequent 
redirection of actin bundles to these clusters was ob-
served. These basolateral CD44/annexin II–lipid raft 
complexes were stabilized by addition of GTP
 
g
 
S or 
 
phalloidin in a semipermeabilized and cholesterol-
depleted cell system. The low lateral mobility of CD44 
in the plasma membrane, as assessed with ﬂuorescent 
recovery after photobleaching (FRAP), was dependent 
on the presence of plasma membrane cholesterol and 
an intact actin cytoskeleton. Disruption of the actin cy-
toskeleton dramatically increased the fraction of CD44 
which could be recovered from the light detergent-
insoluble membrane fraction. Taken together, our data 
indicate that in mammary epithelial cells the vast ma-
jority of CD44 interacts with annexin II in lipid rafts in 
a cholesterol-dependent manner. These CD44-contain-
ing lipid microdomains interact with the underlying ac-
tin cytoskeleton.
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L
 
IPIDS
 
 and lipid derivatives participate in signal trans-
duction events occurring on the plasma membrane,
and regulate plasma membrane–cytoskeleton inter-
actions (Chong et al., 1994; Sun et al., 1995; Hirao et al.,
1996). Moreover, recent developments put forward a con-
cept that certain lipids can organize plasma membrane mi-
crodomains, called lipid rafts, representing high-order
structures. These microdomains are thought to exist as liq-
uid-ordered phases, characterized by a high degree of acyl
chain order, which contain sphingolipids with their pre-
dominantly saturated hydrocarbon tails and cholesterol
(see reviews Brown and London, 1998; Ikonen and Si-
mons, 1998; Brown, 1998). The intervening regions are en-
visioned to be in liquid-disordered membrane phase oc-
cupied by unsaturated phosphatidyl-choline molecules.
Sphingolipid-cholesterol rafts are relatively insoluble in
nonionic detergents (e.g., Triton X-100) on ice, and can be
recovered together with certain membrane proteins as in-
soluble complexes called detergent-insoluble glycolipid-
enriched domains (DIGs)
 
1
 
 (Parton and Simons, 1995).
DIGs can be biochemically distinguished from detergent-
insoluble cytoskeleton-associated material by density gra-
dient centrifugation, where, due to their high lipid content,
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FRAP, fluorescent recovery by photobleaching; M-
 
b
 
-CD, methyl-
 
b
 
-cyclo-
dextrin; PLAP, placental alkaline phosphatase; RhoGDI, Rho GDP dis-
sociation inhibitor; TER, trans-epithelial resistance. 
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they float at a low density, while detergent-insoluble cy-
toskeletal assemblies remain at higher densities.
Cholesterol-rich microdomains differ in size, dynamics,
and protein composition. One type are caveolae, morpho-
logically defined as flask-shaped, noncoated invaginations
of the plasma membrane (for reviews see Lisanti et al.,
1995; Parton, 1996; Shaul and Anderson, 1998). They are
stabilized by oligomers of the integral membrane protein
caveolin/VIP21, which in roughly equimolar stoichiometry
binds cholesterol (Parton and Simons, 1995; Parton, 1996;
Scheiffele et al., 1998). There are several possible func-
tions assigned to caveolae, including participation in signal
transduction (Shenoy-Scaria et al., 1994; Mineo et al.,
1996), lipid transport (Fielding and Fielding, 1997; Thy-
berg et al., 1998; Uittenbogaard et al., 1998), potocytosis
(Smart et al., 1996), and endocytosis/transcytosis (Benli-
mame et al., 1998; Orlandi and Fishman, 1998; Schnitzer et
al., 1994). Recent findings indicate that lipid rafts can also
exist independently of caveolae (for reviews see Parton
and Simons, 1995; Harder and Simons, 1997; Ikonen and
Simons, 1998). They are 
 
,
 
70 nm in size and contain a re-
stricted number of membrane proteins and lipids. Their
existence in living cells was shown recently by assays using
chemical cross-linking and measurement of energy transfer
between fluorescently labeled membrane proteins (Friedrich-
son and Kurzchalia, 1998; Varma and Mayor, 1998). Parti-
tion of peripheral proteins and transmembrane receptors
into cholesterol-rich domains such as lipid rafts or caveo-
lae is in a dynamic equilibrium driven by raft cohesion and
counteracted by entropy-driven dispersal. Lipid rafts can
fuse to form larger and more stable complexes or move to
preexisting caveolae (Harder and Simons, 1997).
Proteins can associate with lipid rafts via at least three
different modes, partitioning into the outer leaflet of lipid
bilayer via glycosyl-phosphatidylinositol (GPI) anchors
(Mayor et al., 1994), associating with the inner leaflet via
acylation, palmitolyation, or direct interaction with choles-
terol (Shenoy-Scaria et al., 1994; Parton et al., 1996;
Mumby, 1997), and/or, for transmembrane proteins such
as the hemagglutinin of influenza virus, partitioning into
lipid rafts due to the intrinsic properties of transmembrane
domains, such as a stretch of hydrophobic residues in con-
tact with the outer leaflet of the plasma membrane
(Scheiffele et al., 1997).
The cell adhesion molecule CD44, the major cell surface
receptor for hyaluronic acid, partitions into lipid rafts in fi-
broblasts (Neame et al., 1995; Perschl et al., 1995a). More-
over, CD44 associates with the activated protein tyrosine
kinases Lck and Fyn in cholesterol-rich Triton X-100–
insoluble plasma membrane domains of human peripheral
blood lymphocytes (Ilangumaran et al., 1998). CD44 is in-
volved in a variety of important biological events such as
pattern formation in embryogenesis, hematopoiesis, lym-
phocyte homing and activation, inflammatory reactions
and tumor dissemination (for reviews see Ruiz et al., 1995;
Günthert, 1996; Naot, 1997; Ponta and Herrlich, 1998;
Günthert, 1999). CD44 represents a large protein family
with most likely variable functional properties. The iso-
forms are generated by alternative splicing of transcripts,
which results in the addition of various stretches of amino
acids in the extracellular part of this protein, and subse-
quent variable glycosylation. However, all CD44 isoforms
studied so far contain common transmembrane and cyto-
plasmic domains.
We have addressed the following questions: (a) Which
type of cholesterol-rich microdomains associates with
CD44 in mammary epithelial cells? (b) Which other pro-
teins are recruited into CD44-containing microdomains?
(c) Do CD44-containing microdomains interact with the
cytoskeleton and how is such an interaction mediated?
 
Materials and Methods
 
Cells, Antibodies, and Reagents
 
Media, tissue culture reagents, and FCS were purchased from GIBCO
BRL and Boehringer Mannheim. As a model system, we used EpH4 cells,
a spontaneously immortalized mouse mammary epithelial cell line which
displays a fully polarized epithelial cell phenotype (Fialka et al., 1996,
1997). EpH4 cells were cultured on permeable filter supports at 37
 
8
 
C, 5%
CO
 
2
 
, and 98% humidity in Eagle’s medium, supplemented with 10 mM
Hepes and KOH (pH 7.3), 50 IU/ml penicillin, 50 mg/ml streptomycin, and
5% FCS. For some of the immunolocalization experiments, Transwell™
filters (no. 3450; Corning Costar Corporation), 24-mm-diam, 0.4-
 
m
 
m pore
size, were used. Transepithelial electrical resistance (TER) of filter-grown
EpH4 monolayers was measured using a Millicell Electrical Resistance
System (Millipore Corporation) equipped with an Endohm-24-electrode
(World Precision Instruments) according to standard procedures.
Hybridoma clone IM7.8.1 (TIB-235; American Type Culture Collec-
tion) (producing rat anti–human/mouse pan CD44 antibodies) was propa-
gated in medium with Ig-depleted FCS and secreted antibody were puri-
fied on protein G–Sepharose columns (Pharmacia). The anti–human
annexin II antibody HH7 is a mouse monoclonal antibody recognizing
murine annexin II (Thiel et al., 1992). Anti-p11 antibody H21 reactive
with a trans-dominant mutant of annexin II was previously described
(Harder and Gerke, 1993). Mouse monoclonal antibody cross-reacting
with mouse annexin II (A14020) and rabbit polyclonal antibody against
caveolin (C13630) were from Transduction Laboratories and mouse mono-
clonal antibody against actin (mAb 1501) as well as rat monoclonal against
ZO-1 (mAb 1520) were purchased from Chemikon. Mouse monoclonal
antibody H68.4 recognizing mouse transferrin receptor was a generous gift
from Dr. J. Trowbridge. Secondary antibodies used for immunofluores-
cence were from Jackson ImmunoResearch Laboratories: Cy3-goat anti–rat
(712-165-150), Cy3-goat anti–mouse (715-160-150), FITC-goat anti–mouse
(115-095-100); and from Molecular Probes: Alexa488-goat anti–rabbit (A-
11008), Alexa488-goat anti–rat (A-11006) and Alexa488-goat anti–mouse
(A-11001). Protease inhibitors aprotinin, pepstatin, leupeptin, and Pefa-
bloc SC were from Boehringer Mannheim. LipofectAMINE PLUS™ Re-
agent was from GIBCO BRL. Reagents for cholesterol depletion included
digitonin (D-1407) and methyl-
 
b
 
-cyclodextrin (M-
 
b
 
-CD, C-4555) both
from Sigma-Aldrich. Rhodamine-phalloidin was purchased from Molec-
ular Probes (R-415). Latrunculin A was a kind gift from Dr. J. Knoblich
(IMP, Vienna).
 
Isolation of Glycosphingolipid-rich Triton
X-100–insoluble Membrane Fractions
 
Confluent cell monolayers were washed twice with cold PBS, scraped in PBS
and spun down at 2,000 rpm at 4
 
8
 
C. Cells were lysed in 200 
 
m
 
l of TN (25 mM
Tris HCl, pH 7.5, 150 mM NaCl, 1 mM DTT, cocktail of protease inhibi-
tors, 10% sucrose, and 1% Triton X-100) on ice, and incubated for 30 min
on ice. Samples were mixed with 400 
 
m
 
l of cold Optiprep™, transferred
into SW60 centrifuge tubes and overlaid with 600 
 
m
 
l of each 35%, 30%,
25%, 20%, and 0% Optiprep™ in TN. The gradients were spun at 35,000
rpm in SW60 rotor for 12 h at 4
 
8
 
C. Fractions were collected from top to
bottom of centrifuge tubes, proteins were precipitated according to Wessel
and Flügge (1984) followed by Western blotting analysis. Only in case of the
anti-panCD44 antibody (IM7.8.1) nonreducing SDS-PAGE was applied.
 
Sequestration of Membrane Cholesterol and 
Cholesterol Measurements
 
The cholesterol sequestration in vivo was performed with M-
 
b
 
-CD
(Klein et al., 1995) in confluent cultures. Monolayers were washed once 
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with PBS, then the prewarmed medium, containing 5 mM of M-
 
b
 
-CD,
was added and cells were incubated for 15 min at 37
 
8
 
C. Cholesterol se-
questration in isolated membrane fractions was achieved by treatment
of pelleted membranes with varying concentrations of digitonin for 30
min on ice. The cholesterol content of pelleted membranes before and
after treatment was determined by an enzymatic-fluorometric assay
(Heider and Boyett, 1978). Values were normalized to total membrane
protein.
 
Clustering of CD44 by Antibody and Expression of the 
Trans-dominant Annexin II Mutant
 
Sparsely grown cells were incubated with anti-panCD44 antibody IM7.8.1
(10 
 
m
 
g/ml) diluted in normal Eagles’s medium for 10 min at 37
 
8
 
C, fol-
lowed by three washes in PBS, containing 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, and
0.5% gelatin. Control cells were fixed in acetone and methanol before
treatment with secondary Cy3-labeled goat polyclonal anti–rat antibodies
to visualize CD44 staining. Clustering of CD44 was induced in the remain-
ing cell samples by incubation with Cy3-labeled goat polyclonal anti–rat
antibodies (20 
 
m
 
g/ml) in the normal Eagle’s medium for 20 min at 37
 
8
 
C;
thereafter, the cells were rinsed and fixed as above. All cell samples were
then double stained with antibodies against annexin II or VIP21 and cave-
olin.
The construction of the trans-dominant mutant of annexin II was de-
scribed previously (Harder and Gerke, 1993). Transient transfections of
sparse EpH4 cells were performed using LipofectAMINE PLUS™ Re-
agent according to the manufacture’s recommendations.
 
Permeabilized EpH4 Cell System, GTP
 
g
 
S, and 
Phalloidin-TRITC Treatment
 
Cells were permeabilized as described in Mackay et al. (1997). In brief,
confluent, filter-grown EpH4 cells were permeabilized at 37
 
8
 
C for 10–20
min using 0.003% digitonin in DK buffer (150 mM potassium glutamate,
10 mM Hepes and KOH, pH 7.3, 5 mM glucose, 2 mM MgCl
 
2
 
, and 0.4 mM
EGTA), supplemented with an ATP-regenerating system (1 mM ATP, 5
mM creatine phosphate, and 10 
 
m
 
g/ml creatine phosphokinase), DTT as
an antioxidizing agent and a cocktail of protease inhibitors. 50 
 
m
 
M of GTP
 
g
 
S
or 0.05–0.1 
 
m
 
M of rhodamine-phalloidin was added to the permeabilized
cells where indicated.
 
Immunofluorescence and Laser Confocal Microscopy
 
Cells were washed twice in PBS, fixed with acetone and methanol (1/1) at
 
2
 
20
 
8
 
C for 2 min, and air-dried. The cells were then washed with PBS and
incubated in blocking buffer (0.5% gelatin in PBS containing 1 mM CaCl
 
2
 
,
and 1 mM MgCl
 
2
 
) at room temperature for 30 min in order to decrease
nonspecific antibody binding. Subsequently, cells were incubated for 1 h
at room temperature with primary antibodies diluted in blocking buffer,
followed by three washes in blocking buffer. Secondary antibodies were
applied in the same way. The samples were mounted in Moviol and pro-
cessed for microscopy. All confocal microscopy images were obtained us-
ing a Leica TCS NT confocal microscope (Leitz). Images were processed
using an Octane Workstation (Silicon Graphics, Inc.) using the Huygens
(Scientific Volume Imaging), Imaris, and Colocalization (Zitplane AG)
software packages.
 
Fluorescence Recovery after Photobleaching
 
The sparse EpH4 cells grown on coverslips were washed briefly with fresh
medium and incubated with FITC-labeled antistandard CD44 antibody
IM7.8.1 (10 
 
m
 
g/ml) diluted in normal Eagles’s medium for 20 min at room
temperature. For the labeling of the transferrin receptor K
 
1
 
-depleted
EpH4 cells (Hansen et al., 1993) were incubated with FITC-labeled trans-
ferrin (50 
 
m
 
g/ml) for 20 min on ice. The cells were rinsed with medium to
remove nonbound antibody and the coverslips were assembled into the
perfusion chamber (H. Saur Laborbedarf, Reutlingen, Germany) and con-
nected to the peristaltic pump, allowing the exchange of the medium and
maintaining cells at 37
 
8
 
C. Initial imaging, photobleaching of the selected
regions of the plasma membrane, and recording of the fluorescent recov-
ery were performed in a Leica TCS NT confocal microscope system
(Leitz). The bleached areas had a surface area of 
 
z
 
40 
 
m
 
m
 
2
 
. The fluores-
cence recovery was recorded immediately using a time-lapse option of the
system. The data obtained were analyzed using TCS NT quantification
software. The intensities of the bleached and recovered regions were nor-
malized in regard to the fluorescent intensity of the independent region in
the same samples. The percentage of recovery was calculated as Ir /Ii,
multiplied by 100%, where Ir is the intensity of the photobleached region
after  recovery and Ii is the intensity of the selected region before pho-
tobleaching.
 
Results
 
CD44 and Annexin II Partition into Lipid Rafts and 
Colocalize in the Basolateral Plasma Membrane of 
Mouse Mammary Epithelial Cells
 
In fibroblasts, 
 
#
 
50% of CD44 is resistant to Triton X-100
extraction (Lacy and Underhill, 1987; Neame et al., 1995;
Perschl et al., 1995a). However, in Madin-Darby canine
(MDCK) and bovine (MDBK) kidney epithelial cells
CD44 was completely soluble in Triton X-100 and no asso-
ciation of CD44 with the cytoskeleton could be demon-
strated (Neame and Isacke, 1993; Neame et al., 1995). We
used the Triton X-100 solubility assay to explore a possible
cytoskeletal association of CD44 in the EpH4 mammary
epithelial cell line. The majority of CD44 remained in the
insoluble fraction after Triton X-100 extraction at concen-
trations up to 1% (data not shown).
We tested whether Triton X-100 insolubility of CD44
could be a consequence of its localization in Triton X-100–
insoluble membrane domains (Neame et al., 1995; Perschl
et al., 1995a; Ilangumaran et al., 1998). Therefore, we per-
formed floatation experiments in Optiprep™ gradients in
the presence of Triton X-100. In this gradient, detergent-
insoluble, glycosphingolipid-rich membrane fractions rep-
resenting the lipid rafts will float to the interphase be-
tween the 0% and 20% Optiprep™ layers. Solubilized
proteins or cytoskeleton-associated, detergent-insoluble
proteins remain at the bottom of the gradient. In EpH4
cells, a fraction of CD44 isoforms floated to low density
fractions, together with the detergent-resistant glycosphin-
golipid-rich membranes (Fig. 1 A). There were several
bands detected by anti-panCD44 antibody (IM7.8.1) by
Western blot, due to the fact that there are several CD44
isoforms expressed in EpH4 cells, as revealed by RT-PCR
(data not shown). However, all isoforms partitioned into
the lipid raft fractions with the same efficiency. The total
amount of CD44 that could be recovered from lipid raft
fractions under experimental conditions described above
was determined as a result of three independent experi-
ments, indicating that in a steady state 
 
z
 
35% of CD44
partitions into lipid rafts as assessed by Optiprep™ gradi-
ent floatation, followed by Western blot (Fig. 1 A). Caveo-
lin/VIP21, a known cholesterol-binding protein, was found
in the same lipid raft fractions. A second lipid-binding pro-
tein, annexin II, also efficiently partitioned to this fraction
(Fig. 1 A). However, addition of the Ca
 
2
 
1
 
-chelating agent
EDTA to the homogenization buffer reduced this effi-
ciency to 
 
,
 
10%, while CD44 distribution over the gradi-
ent did not change (data not shown). This suggested a
Ca
 
2
 
1
 
-dependent association of annexin II with choles-
terol-rich membranes. In contrast, the transferrin recep-
tor, a transmembrane protein localized to clathrin-coated
pits, was always found to be associated with heavier frac-
tions and never occurred in lipid rafts, confirming the cor-
rect partitioning of different membrane proteins in the
gradient (Fig. 1 A). 
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Our biochemical analysis suggested that CD44 occurred
in detergent-insoluble lipid rafts, together with caveolin/
VIP21 and annexin II. Both proteins are located basolater-
ally in EpH4 cells (Fig. 1 C). However, they may be incor-
porated into different subtypes of basolateral lipid rafts.
Caveolin/VIP21 is a structural component of caveolae
(Parton, 1996), but a minor fraction is localized within the
entire plasma membrane (Wary et al., 1998). In EpH4
cells, CD44 isoforms mostly failed to colocalize with cave-
olin/VIP21, indicating that CD44-containing lipid rafts
represent structures distinct from caveolae (see lower part
of Fig. 1 C for x-z axis visualization). However, CD44 was
found to colocalize with annexin II along the basolateral
plasma membrane domain (Fig. 1 C, upper part).
Colocalization of annexin II with CD44 in the lateral
membrane of EpH4 cells was dependent on an intact lipid
environment. To reduce the plasma membrane cholesterol
concentration, we treated cells with the cholesterol-seques-
tering drug, M-
 
b
 
-CD (Klein et al., 1995), before fixation.
M-
 
b
 
-CD forms stable inclusion complexes with choles-
terol by incorporating it into its hydrophobic cavity. Typi-
cally, treatment of confluent EpH4 monolayers reduced
cholesterol from 25 to 9.5 
 
m
 
g cholesterol/mg membrane
protein as revealed by an enzymatic fluorometric assay
(Heider and Boyett, 1978). Upon depletion of membrane
cholesterol by M-
 
b
 
-CD, both CD44 and annexin II re-
distributed to the entire plasma membrane, including the
apical domain and were no longer colocalized (data not
shown).
 
Annexin II Can Be Recruited into Antibody-induced 
CD44 Clusters
 
One of the possibilities to selectively analyze microdo-
mains enriched in CD44 is to use in vivo antibody labeling
of CD44 followed by cross-linking of CD44–antibody
complexes with secondary antibodies in living cells. In
sparsely grown EpH4 cells labeled with primary anti-
CD44 antibodies followed by immediate fixation, both
CD44 and annexin II were diffusely distributed all over
the plasma membrane (Fig. 2, A–C). After cross-linking of
CD44 in intact cells with anti-CD44 plus secondary anti-
bodies, we observed that most of CD44 accumulated in big
patches on the plasma membrane. Interestingly, these
patches also contained annexin II, apparently recruited
into these complexes at the cytosolic face of the plasma
Figure 1. CD44 and annexin
II are recovered in the lipid
raft fractions and colocalize
in the basolateral plasma
membrane of EpH4 cells.
Cells were lysed in buffer
containing 1% Triton X-100
on ice in the absence of Ca21-
chelating agents. Floatation
was performed in Opti-
prep™ gradients and frac-
tions were collected, pre-
cipitated, and then equal
amounts of total proteins
were analyzed by Western
blotting using antibodies to
CD44, caveolin/VIP21, trans-
ferrin receptor (Tfn-R), and
annexin II (A). Anti-
panCD44 antibody IM 7.8.1
recognizes a standard 85-kD
isoform and a number of
high molecular mass variant
isoforms. CD44 and caveo-
lin/VIP21 are localized to the
floated raft fractions. As ex-
pected, the control protein
transferrin receptor could
not be floated to the lipid
raft fraction. The bulk of a
lipid-binding protein annexin
II can be found in the lipid
raft fraction, too. Molecular
mass markers are given in ki-
lodaltons. When fractions from the Optiprep™ gradients were loaded by yield, the total efficiency of CD44 partition into the lipid rafts
was determined as a result of three independent experiments (B). The mean percentages of standard (empty bars) and variant (full
bars) CD44 isoforms with standard deviations are given. Confluent filter-grown monolayers of EpH4 were fixed in acetone and metha-
nol and subjected to indirect immunofluorescence using anti-CD44 plus anti–annexin II or anti-CD44 plus anti-caveolin/VIP21 antibod-
ies, respectively. Vertical (x-z axis) section images taken by confocal microscopy and image processing (see Materials and Methods) are
shown. CD44 colocalized with annexin II in the basolateral plasma membrane (C, upper panel). However, CD44 virtually did not colo-
calize with caveolin/VIP21 (C, lower panel). Bar, 10 mm. 
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membrane (Fig. 2, D–F). In contrast, no significant colo-
calization of CD44 and caveolin/VIP21 was observed us-
ing anti-caveolin/VIP21 antibodies, either before (Fig. 2,
G–I) or after antibody cross-linking of CD44 (Fig. 2, J–L).
These results were consistent with our hypothesis that
CD44-containing lipid rafts were distinct from the caveo-
lae submembranous compartment.
We previously found that the colocalization of CD44
and annexin II in lipid rafts was impaired after depletion
of the cells from cholesterol by M-
 
b
 
-CD (data not shown).
Therefore, it was of interest to analyze if M-
 
b
 
-CD would
also impair the formation of patches after CD44 antibody
cross-linking and prevent the inclusion of annexin II into
these patches. Interestingly, the ability of CD44 to form
clusters upon antibody cross-linking was significantly re-
duced by pretreatment of cells with 5 mM M-
 
b
 
-CD.
Smaller clusters formed upon cross-linking failed to re-
cruit annexin II (Fig. 3, A–C).
 
Aggregation of a Trans-dominant Annexin II Mutant 
Induces Coclustering of CD44 and the Minor 
Rearrangements of the Actin Cytoskeleton
 
In most cell lines studied so far, annexin II exists as a het-
erotetramer bound to its ligand p11. The chimeric p11–
annexin II protein inducing the aggregation of endoge-
nous annexin II and p11 was previously described (Harder
and Gerke, 1993). In brief, it is a chimeric protein compris-
ing the NH
 
2
 
-terminal domain of annexin II fused to the
NH
 
2
 
 terminus of p11. As a result, this mutant has two
binding sites for p11 and one for annexin II. p11 dimers
bound to this chimera would accommodate additional
Figure 2. Annexin II is efficiently
recruited to patches of anti-
body cross-linked CD44 micro-
domains. EpH4 cells grown at low
cell density on coverslips were la-
beled with anti-CD44 antibody.
Control samples (A–C and G–I)
were fixed and then stained with
secondary goat anti–rat antibody,
while experimental samples were
treated with secondary anti–rat
IgG before fixation, causing in vivo
cross-linking of CD44 on the cell
surface (D–F and J–L). Control
and experimental samples were
then counterstained with anti-
annexin II antibody (A–F) or anti-
caveolin/VIP21 antibody (G–L). In
control cells, CD44 (A) and an-
nexin II (B, see merged images in
C) were evenly distributed over
the entire plasma membrane.
Upon antibody cross-linking CD44
as well as annexin II could be
found in patch-like clusters on the
surface of the cells (D, E, merge
see F). In contrast, caveolin/
VIP21 was located in larger spots
most likely representing caveolae
before or after antibody cross-
linking of CD44 and failed to
colocalize with CD44 in control-
(G–I) or cross-linked (J–L) cells.
Bar, 10 mM. 
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sites for binding of chimera and/or annexin II–p11 com-
plexes, leading to the formation of the large aggregates
containing annexin II, p11, and the chimeric protein. In
nonpolarized EpH4 cells transiently expressing the mu-
tant, the appearance of large annexin II–p11-positive clus-
ters underneath the plasma membrane was observed (Fig.
4 A). The extent of aggregate formation was dependent on
the levels of expression. Most interestingly, CD44 was also
redistributed in the plasma membrane of transfected cells,
largely colocalizing with trans-dominant annexin II (Fig. 4
B). Actin cytoskeleton was rearranged in transfected cells,
and the ends of the actin bundles were often found colo-
calizing with the clusters of trans-dominant mutant (Fig. 4
C, see D for the merge of three colors).
 
CD44/Annexin II–containing Lipid Rafts Can Be 
Stabilized in the Basolateral Plasma Membrane 
following the Increased Polymerization of the
Actin Cytoskeleton
 
To further characterize CD44/annexin II–containing lipid
rafts, we tested whether the stability of these complexes
with respect to cholesterol depletion was dependent on di-
rect or indirect interaction with the actin cytoskeleton.
Figure 3. CD44 clustering in-
duced by antibody cross-linking is
significantly impaired in choles-
terol-depleted cells. Sparsely seeded
EpH4 cells (see Fig. 2) were pre-
treated with M-b-CD and processed
as described in the legend to Fig. 2,
using only costaining with anti-
annexin II antibody. In M-b-CD–
treated cells, antibody cross-linking
of CD44 produced much smaller
clusters (A) than in untreated
cells, (compare with Fig. 2 D) and
annexin II (B, merge in C) was no
longer recruited to these small
patches. Bar, 10 mm.
Figure 4. Aggregation of trans-domi-
nant mutant of annexin II causes co-
clustering of the plasma membrane
CD44. Sparsely grown EpH4 cells were
transiently transfected with expression
construct pCMV XM driving the ex-
pression of trans-dominant mutant of
annexin II. After z48 h the expression
of this construct caused formation of
the relatively large aggregates of mu-
tant annexin II underneath the plasma
membrane (A). As evident from com-
parison with surrounding nontrans-
fected cells, CD44 in transfected cells
was found to cocluster with annexin II–
p11 aggregates, visualized by p11 anti-
body H21 (B). In some cases actin cy-
toskeleton was rearranged too and actin
fibers were colocalizing with CD44–
annexin II clusters (C). Merge image of
this triple-labeling experiment is shown
in D. There are zoomed-in images of
the regions of the plasma membrane on
the magnified insets in corresponding
panels. Bar, 10 mm. 
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The first approach was to test if active GTP-binding pro-
teins were required for CD44-containing lipid raft stabil-
ity, using a nonhydrolyzable GTP analogue (GTP
 
g
 
S). To
allow the use of GTP
 
g
 
S, we adapted a method to generate
semipermeabilized cells described by Mackay et al. (1997)
to our polarized, filter-grown EpH4 cells. For this, EpH4
cells were permeabilized by very low concentrations of dig-
itonin (0.003%), a known cholesterol-sequestering deter-
gent (Elias et al., 1978). This treatment depleted choles-
terol from EpH4 cells twice as efficient than M-
 
b
 
-CD
(from 25 to 3.9 
 
m
 
g cholesterol/mg membrane protein, see
above). The permeabilized cells were supplemented with
an ATP-regenerating system, a cocktail of protease inhibi-
tors, and with DTT as antioxidant. Under these conditions
we could observe the redistribution of CD44 and annexin
II over the entire plasma membrane (Fig. 5, A–C). How-
ever, when nonhydrolyzable GTP
 
g
 
S was added to the cells
during digitonin treatment no redistribution to the apical
membrane occurred, and CD44 and annexin II continued
to be colocalized in the basolateral plasma membrane do-
main (Fig. 5, D–F).
One obvious consequence of arresting small Rho-GTP-
ases in their active state (as caused by GTP
 
g
 
S) is the stabi-
lization of filamentous actin cables (Ridley and Hall,
1992), as suggested by our observation that this treatment
resulted in appearance of thicker bundles of stress fibers
and a more prominent subcortical actin ring (not shown).
Thus, a possibility to explain the above results was that
GTP
 
g
 
S treatment stabilized CD44-containing lipid rafts in
the basolateral plasma membrane through their enhanced
interaction with stabilized, underlying actin cables under
these experimental conditions. To test for this possibility,
we chose an alternative way to stabilize F-actin filament
bundles, using the fungal toxin phalloidin. The phalloidin-
stabilized actin filaments still retain some of their func-
tional properties; for example, they are able to move on
solid-phase myosin substrates (Kinosita et al., 1991). This
experiment was performed in the same digitonin-semiper-
meabilized EpH4 cell system as described above. While
digitonin permeabilization caused redistribution of CD44
in the control cells (Fig. 6 A), treatment of the cells with
phalloidin during digitonin-induced cholesterol depletion
fully mimicked the activity of GTP
 
g
 
S. CD44 remained un-
detectable on the apical surface of phalloidin-treated cells
after the depletion of plasma membrane cholesterol (Fig. 6
C). At the same time, the subcortical actin ring was stabi-
lized (Fig. 6 D). These results suggest that the stability of
lipid rafts containing CD44 also requires intact actin fila-
ment bundles and/or an interaction of the proteins present
in the lipid rafts with the underlying cytoskeleton.
Figure 5. Activation of GTP-binding
proteins by GTPgS prevents redistribu-
tion of CD44 and annexin II upon de-
pletion of plasma membrane choles-
terol by digitonin. Confocal vertical
(x-z) sections of digitonin-treated EpH4
cells are shown. In filter-grown cells
subjected to cholesterol depletion and
semipermeabilization with digitonin,
both CD44 (A) and annexin II (B)
could be found at the apical surface af-
ter fixation and respective antibody
staining. However, when GTPgS was
added to the permeabilization buffer,
neither CD44 (D) nor annexin II (E) underwent redistribution, but remained colocalized at the basolateral cell membrane domain.
Merged images are shown in C and F. Bar, 10 mm.
Figure 6. Stabilization of actin by phalloidin prevents redistribu-
tion of CD44 upon digitonin-induced depletion of plasma mem-
brane cholesterol. Extended focus images and vertical (x-z) sec-
tions are shown. In digitonin-permeabilized EpH4 cells, CD44
stained by the respective antibody was redistributed to the apical
surface (A; similar to the experiment shown in Fig. 5). The actin
cytoskeleton is visualized by phalloidin-rhodamine, failing to
show an extensive subcortical actin ring in many cells (B). When
phalloidin was added to the permeabilization buffer (see Fig. 5),
CD44 remained precisely localized to the basolateral plasma
membrane domain (C). Phalloidin-rhodamine showed enhanced
staining of filamentous actin and stabilization of the subcortical
actin ring upon treatment with phalloidin (D). Bar, 10 mm. 
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CD44-containing Lipid Rafts Interact with the 
Underlying Actin Cytoskeleton
 
Looking for the biochemical evidence that CD44-contain-
ing lipid rafts interact with the actin cytoskeleton, we de-
cided to treat EpH4 cells with the actin cytoskeleton-dis-
rupting drug latrunculin A before the lipid rafts floatation
experiment. To our surprise, the proportion of CD44 in
the detergent-insoluble, glycosphingolipid-rich membrane
fractions increased dramatically (Fig. 7 A, lower panel), as
compared with the mock-treated control (Fig. 7 A, upper
panel). These results indicate that a significant bulk of
CD44-containing lipid rafts is not capable of floating up to
the light lipid rafts fractions due to its interaction with the
heavy cytoskeleton elements. This experiment further im-
plied that the vast majority of CD44 molecules in EpH4
cells is localized to the lipid rafts.
To obtain complimentary evidence that CD44-contain-
ing lipid rafts do indeed interact with the underlying actin
cytoskeleton, we employed a technique known as fluores-
cence recovery after photobleaching (FRAP). In brief,
CD44 molecules on the surface of living cells were labeled
with FITC-labeled anti-panCD44 antibody IM7.8.1. The
selected regions of the plasma membrane were bleached
and the subsequent recovery of the bleached regions was
recorded. The absolute values obtained were normalized
by comparison with the fluorescent intensities in an inde-
pendent region of identical size. These lateral diffusion
measurements indicated that CD44 molecules were virtu-
ally immobilized in the plasma membrane of control cells,
as compared with the transferrin receptor, a transmem-
brane protein of clathrin-coated pits (Fig. 7 B) or free lipid
dye BODIPY-FL-sphingomyelin (data not shown). The
FRAP measurements of the lateral mobility of the trans-
ferrin receptor were performed in K
 
1
 
-depleted cells in or-
der to prevent receptor internalization (Hansen et al.,
1993). However, the lateral mobility of CD44 was notably
improved in the cells pretreated with either M-
 
b
 
-CD or
actin disrupting drug latrunculin A (Fig. 7 B). For in-
stance, the percentage of recovery of the photobleached
region in control cells after 105 s was 
 
z
 
19%, in compari-
son with 28% and 40% in M-
 
b
 
-CD–treated and latruncu-
lin A–treated cells, respectively. This finding indicates that
lateral mobility of CD44 molecules in the plasma mem-
brane is dependent on the presence of the plasma mem-
brane cholesterol and an intact actin cytoskeleton, again
suggesting the direct interaction of lipid raft–associated
CD44 with underlying cytoskeleton.
 
Discussion
 
Association of CD44 and Annexin II with the Same 
Type of Lipid Rafts
 
In unpolarized, sparsely seeded epithelial cells, CD44 dis-
tributes over the entire plasma membrane, including mi-
crovilli, and areas of cell-to-cell contacts. As epithelial
cells polarize CD44 redistributes to the basolateral surface
of the plasma membrane and all isoforms looked at so far
localize exclusively within this plasma membrane domain
(Isacke, 1994). In MDCK cells the localization and restric-
tion of the standard form of CD44 (CD44s) to the lateral
cell surface depends on a critical dileucine motif in the cy-
toplasmic tail of the protein (Neame and Isacke, 1993).
This motif serves as a dominant localization signal since it
is also able to redirect the normally apical protein placen-
tal alkaline phosphatase (PLAP) to the basolateral plasma
membrane (Sheikh and Isacke, 1996).
In polarized EpH4 mammary epithelial cells, the stan-
dard and several variant CD44 isoforms are expressed en-
dogenously and all localize to the basolateral plasma
membrane domain. Previous studies in polarized MDCK
cells showed that CD44 was completely Triton X-100 solu-
ble (Neame and Isacke, 1993; Isacke, 1994; Neame et al.,
1995). However, we found in EpH4 cells that a majority of
CD44 could not be extracted by Triton X-100 at 4
 
8
 
C.
Other authors reported previously that CD44 insolubility
can be attributed to its partition into Triton X-100–insolu-
ble lipid microdomains in certain cell types (Neame et al.,
1995; Ilangumaran et al., 1998). To test this hypothesis, we
floated Triton X-100–insoluble material on Optiprep™
density gradients and were able to show that in EpH4 cells
a significant portion of all CD44 isoforms was present in
lipid rafts.
How could CD44 partition into basolateral lipid rafts in
Figure 7. CD44-containing lipid rafts in-
teract with the actin cytoskeleton. To fur-
ther assess the possibility of the direct in-
teraction of CD44-containing lipid rafts
with the actin cytoskeleton, the Op-
tiprep™ gradient floatation following the
disruption of the actin cytoskeleton by la-
trunculin A was performed. A vast major-
ity of CD44 was now found in the floating
lipid rafts–rich fraction (A, lower panel)
in comparison with control cells (A, upper
panel). Molecular mass markers are given
in kilodaltons. The measurements of
FRAP of CD44 in the plasma membrane
of EpH4 cells were made as described in
Materials and Methods and percentages
of recovery of labeled proteins are shown
(B). The lateral mobility of CD44 was dependent on the intact actin cytoskeleton and the presence of the plasma membrane cholesterol.
The transmembrane protein of clathrin-coated pits, the transferrin receptor, was used as a control. Mean 6 SE values are shown. 
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epithelial cells? CD44 might first partition into basolateral
TGN-derived vesicles, due to its active basolateral sorting
signal. Upon arrival at the basolateral membrane domain,
CD44 might then partition into lipid rafts due to the intrin-
sic properties of its transmembrane domain. Alternatively,
CD44 might partition into cholesterol-rich membranes al-
ready in the TGN, causing these vesicles to be sorted baso-
laterally instead of apically, due to the dihydrophobic sort-
ing motif Leu331/Val332. This scenario would result not
only in proper basolateral sorting of CD44, but would also
recruit cholesterol-rich membranes to the basolateral sur-
face, allowing CD44 to serve as an assembly anchor for ba-
solateral lipid rafts.
One of the proteins expected to localize to cholesterol-
rich membrane domains was caveolin/VIP21. However,
the bulk of CD44 did not colocalize with caveolin/VIP21
in EpH4 cells and the observed minor colocalization did
not occur in deep plasma membrane invaginations indica-
tive of caveolae. A considerable degree of overlap has
been previously observed between CD44 and annexin II in
Triton X-100–extracted fibroblasts, as revealed by immuno-
fluorescence analysis (Neame and Isacke, 1993). We ob-
served a colocalization between CD44 and annexin II in
EpH4 cells. In addition, the depletion of membrane cho-
lesterol by M-
 
b
 
-CD abolished this colocalization, causing
redistribution of both CD44 and annexin II over the entire
cell surface, including the apical plasma membrane. This
drug preferentially extracts cholesterol from the outer
leaflet of the plasma membrane and partially liberates
transmembrane and GPI-anchored proteins from lipid
rafts, leaving caveolae virtually intact (Ilangumaran and
Hoessli, 1998). Together, these observations suggest that
CD44 partitions into lipid rafts but not into caveolae.
Annexin II is a Ca
 
2
 
1
 
-binding protein present in a wide
variety of cells and tissues which can associate with actin
filaments and membranes. Within cells, annexin II occurs
either as a 36-kD monomer (p36) or as a heterotetrameric
complex (p90) coupled with the S-100–related protein, p11
(Kube et al., 1992; Harder and Gerke, 1994). Annexin II
has been suggested to be involved in membrane transport,
both the regulated exocytic pathway (Creutz, 1992) and
the endocytic pathway (Emans et al., 1993; Harder and
Gerke, 1993). In addition, annexin II is a major cellular
substrate for the src-family of protein kinases (Hubaishy
et al., 1995) which partition into lipid rafts in various cell
types (Rodgers et al., 1994; Shenoy-Scaria et al., 1994).
Also it has been implicated that annexin II might interact
with the submembranous actin network with this activity
depending on its ability to form the heterotetrameric
annexin II–p11 complex and on the presence of intact
Ca21-binding sites (Thiel et al., 1992). It has been shown
previously that interaction of the annexin II–p11 hetero-
tetramer with the plasma membrane, but not with the
submembranous cytoskeleton, induces the tyrosine phos-
phorylation of annexin II, presumably exposing the tyrosine-
phosphorylation site as a consequence of induced confor-
mational changes (Bellagamba et al., 1997). Moreover,
recent work indicated that approximately half of the cellu-
lar annexin II Ca21 independently binds to BHK mem-
branes where it may be involved in organizing lipid micro-
domains (Harder et al., 1997). Interestingly, this pool of
annexin II is released upon cholesterol sequestration. In
EpH4 cells only a minor fraction of annexin II was associ-
ated with detergent-insoluble membranes in a Ca21-inde-
pendent manner (data not shown), while the bulk of cellu-
lar annexin II was bound to rafts in the presence of Ca21.
Our findings also clearly agree with the earlier observation
that the annexin II– p11 tetramer is significantly enriched
in the Triton X-100–insoluble fraction of MDCK cells in
the presence of Ca21 (Harder and Gerke, 1994). It is
tempting to speculate, that the interaction of annexin II
with lipid rafts in living cells may be regulated by elevated
intracellular Ca21 concentrations and/or phosphorylation.
Interestingly, another member of the annexin family, an-
nexin XIIIb was also found in the Triton X-100–insoluble
fraction of MDCK cells. Annexin XIIIb is associated with
the apical plasma membrane, enriched in apical transport
vesicles and is involved in apical delivery of TGN-derived
transport vesicles (Lafont et al., 1998). Thus, annexin II
and annexin XIIIb associate with Triton X-100–insoluble
fractions from different cellular locations. These data sug-
gest that, at least in MDCK and EpH4 cells, different an-
nexins might organize rafts and/or modulate raft function
in distinct locations; e.g., by stabilizing inner leaflets of
sphingolipid-cholesterol rafts (Harder and Simons, 1997).
Artificial clustering of the smallest 85-kD isoform of
CD44 (CD44s) has previously been shown to promote
binding of the protein to soluble hyaluronic acid (HA)
(Lesley et al., 1993; Perschl et al., 1995b). In rat pancreatic
carcinoma cells, CD44 splice variants, but not the standard
CD44, form molecular aggregates within the plasma mem-
brane. It was postulated that the regulation of clustering,
mediated by either the presence of variant exons and/or
glycosylation, allows cells in turn to regulate the binding
properties of CD44 to HA (Sleeman et al., 1996). It was
also shown that Cys286 within the transmembrane domain
of CD44 was required for TPA-induced covalent dimer-
ization of CD44 and enhanced HA binding (Liu and Sy,
1997).
These observations prompted us to cluster CD44 on the
cell surface by antibodies. This clustering of CD44 induced
efficient coclustering with annexin II. Significant amounts
of annexin II at the cytoplasmic face of the plasma mem-
brane were recruited into these clusters. Most importantly,
both clustering of CD44 by antibodies and recruitment of
annexin II to these clusters were dependent on the pres-
ence of membrane cholesterol. The fact that the antibody-
induced patches were practically devoid of caveolin/VIP21
again confirmed that CD44–annexin II lipid rafts were dis-
tinct from caveolae. Neither did CD44 colocalize with the
transferrin receptor (not shown), an integral membrane
protein of clathrin-coated pits which is virtually excluded
from lipid rafts (Harder et al., 1998).
The possibility of artificial clustering of annexin II was
previously described (Harder and Gerke, 1993). Expres-
sion of an annexin II–p11 chimera, acting as a trans-domi-
nant mutant, causes aggregation of annexin II–p11 tetra-
mers. This therefore interferes with the normal distribution
of annexin II, and may also alter annexin II–dependent
proteins and/or structures. We observed the formation of
annexin II–positive clusters underneath the plasma mem-
brane of transiently transfected cells. These complexes
also contained CD44 and, interestingly, the actin cytoskel-
eton was rearranged. Actin bundles were either surround-The Journal of Cell Biology, Volume 146, 1999 852
ing or coclustering with annexin II aggregates. In previous
work using the same mutant it was reported that in
MDCK cells the formation of annexin II–p11 aggregates
did not affect the actin-based cell cortex, but translocated
early endosomes (Harder and Gerke, 1993). The difference
between aggregates formed in MDCK and EpH4 cells and
their morphological consequences can be attributed to the
different cell types used and distinct experimental tech-
niques. Our observation that annexin II aggregation
caused both coclustering of CD44 and rearrangements of
the actin cytoskeleton strongly suggested that annexin II
might participate in a functionally important clustering of
CD44-containing lipid rafts in the plasma membrane and
their coupling to the actin cytoskeleton.
CD44-containing Lipid Rafts Interact with the
Actin Cytoskeleton
In fibroblasts, CD44 was previously found to interact with
proteins of the ERM (ezrin-radixin-moesin) family, which
are peripheral actin cross-linkers (Hirao et al., 1996). In
turn, ERM proteins directly interact with Rho GDP disso-
ciation inhibitor (RhoGDI). This reduces RhoGDI activ-
ity and thus activates Rho subfamily members (Hirao et
al., 1996; Takahashi et al., 1997). These results suggest that
members of the ERM family as well as RhoGDI and
RhoGDP/GTP exchange factor are involved in the activa-
tion of the Rho subfamily members, which in turn regulate
reorganization of actin filaments underneath the plasma
membrane. For instance, RhoA appears to regulate actin
stress fibers at the basal membrane representing a ground
state from which epithelial structures are built, whereas
Rac1 activity appears to be required to assemble circum-
ferential actin structures at the lateral membrane which af-
fect the distribution of actin-associated membrane pro-
teins (Jou and Nelson, 1998). In line with this, members of
the ERM protein family could reconstitute stress fiber as-
sembly, cortical actin polymerization and focal complex
formation in response to activation of Rho and Rac in digi-
tonin-permeabilized fibroblasts (Mackay et al., 1997). CD44
interacting with ERM can provide the necessary link to the
plasma membrane (Hirao et al., 1996). We performed im-
munoprecipitation analysis with anti-CD44 antibodies in
EpH4 cells, but we were unable to detect the presence
of ERM proteins or ankyrin/fodrin (Bourguignon et al.,
1998) in immunoprecipitates with anti-panCD44 antibod-
ies (data not shown). However, the rearrangement of the
actin cytoskeleton after expression of trans-dominant an-
nexin II mutant suggested the possible involvement of an-
nexin II in linking of CD44-containing lipid rafts to the cy-
toskeleton.
This prompted us to ask if changes in actin cytoskeleton
structure or stability might alter the integrity and localiza-
tion of CD44–annexin II lipid rafts. Therefore, EpH4 cells
were treated with digitonin to deplete them from choles-
terol and at the same time render them permeable to
GTPgS, a nonhydrolyzable analogue of GTP, which locks
GTP-binding proteins in their active state. GTPgS is a
pleiotropic reagent affecting many different classes of GTP-
binding proteins. However, one of the major consequences
of treating the cells with GTPgS is an increased actin poly-
merization. Adapting the method described by Mackay et
al. (1997) to our fully polarized EpH4 cells, disruption of
the association between CD44 and annexin II as well as
their redistribution to the apical cell surface could be com-
pletely prevented by GTPgS, maintaining colocalized
CD44 and annexin II in the basolateral plasma membrane
domain despite of the cholesterol depletion. GTPgS also
enhanced the formation of stress fibers and the formation
of a pronounced subcortical actin ring (data not shown).
Stabilization of filamentous actin itself by phalloidin also
protected CD44–annexin II membrane complexes from
dissociation and redistribution by cholesterol depletion,
suggesting a direct involvement of stabilized actin fila-
ments in this process.
One of the direct possibilities to address the question
whether CD44-containing lipid rafts interact with the actin
cytoskeleton are the measurements of FRAP. Surpris-
ingly, CD44 exhibited distinct recovery rates in different
sites of the sparsely grown, nonpolarized EpH4 cells. The
mobility rate was lower in the ventral and trailing regions
of the cells than at the leading edge. This difference may
reflect weaker coupling of CD44 to the underlying cyto-
skeleton in the dynamic leading edge region. Interestingly,
our results are in line with the observations by Jacobson et
al. (1984). The diffusion coefficient of an 80-kD glycopro-
tein that they studied and which was identified several
years later as CD44, was threefold higher near the leading
edge of motile cells compared with the trailing region.
However, when the fluorescence recovery rates were mea-
sured in arbitrary regions of the cells, typically ventral or
trailing, it was clear that the extent of the lateral mobility
of CD44 was dependent on the state of the actin cytoskele-
ton and lipid composition of the plasma membrane. Thus,
the lateral mobility of CD44 was significantly enhanced
when either the actin cytoskeleton was disrupted by la-
trunculin A or the plasma membrane cholesterol was de-
pleted by M-b-CD. This observation would support our
hypothesis that CD44 interacts with the actin cytoskeleton
in a cholesterol-dependent manner. In addition, there is
significantly more CD44 floating to the lipid rafts fraction
after the disruption of the actin cytoskeleton by latruncu-
lin A, which again argues for the interaction of CD44 with
actin taking place in the lipid rafts.
Annexin II could fulfill a cross-linker function in several
ways. First, it might directly link CD44 with actin, which
could be achieved by its interaction with CD44 on a pro-
tein–protein level. However, our experiments do not point
in this direction. Alternatively, annexin II can either mod-
ify rafts, therefore, ensuring the possibility of their interac-
tion with the cytoskeleton via different means, or, due to
its high affinity to lipids, cross-link entire raft structures to
the underlying actin cables. Clearly, more work will be re-
quired to resolve these exciting questions.
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